Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca. 论文
2001The American Journal of Cardiology引用 415
Lipoproteins and Cardiovascular HealthComputational Drug Discovery MethodsCancer, Lipids, and Metabolism